Its not like its a sexy stock with loads of sizzle to sell at the moment Mark has done good in prior posts as leader and demonstates MLA potential by buying up around the 1c mark ( pre cons)The company profile looks good and now we wait to see how the recent acquistions go I thought we got medivet for a bargain,and stem cell tech will only become more and more popular as the tech becomes integrated into mainline medical procedures here and abroad
MLA Price at posting:
10.0¢ Sentiment: None Disclosure: Not Held